Preferred Label : nomegestrol acetate;

MeSH note : do not confuse with Solastic;

CISMeF synonym : silastic nomegestrol acetate; 17-hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione 17-acetate; TX 066;

MeSH hyponym : TX-066;

MeSH Related Number : 58652-20-3;

Registry Number MeSH : 58652-20-3;

Codes EINECS : 261-379-8;

Is substance : O;

UNII : 83J78V5W05;

InChIKey : IIVBFTNIGYRNQY-YQLZSBIMSA-N;

Details


Main resources

You can consult :


https://ansm.sante.fr/actualites/contraception-orale-et-risque-de-meningiome-nous-creons-un-comite-dexpert
2024
false
false
false
France
French
drug information
cyproterone acetate
nomegestrol acetate
progesterone congeners
chlormadinone acetate

---
https://ansm.sante.fr/tableau-marr/acetate-de-nomegestrol
2024
false
false
false
France
French
drug information
risk management
nomegestrol acetate
nomegestrol
progesterone congeners
administration, oral
risk
meningioma
continuity of patient care
patients guideline

---
https://www.has-sante.fr/jcms/p_3459822/fr/lutenyl-acetate-de-nomegestrol-gynecologie
2023
false
false
false
France
nomegestrol acetate
risk assessment
treatment outcome
meningioma
nomegestrol
premenopause
hormone replacement therapy
menstruation disturbances
menopause
progesterone
evaluation of the transparency committee
nomegestrol acetate

---
https://ansm.sante.fr/dossiers-thematiques/lutenyl-luteran
2022
false
true
false
France
French
progesterone congeners
chlormadinone acetate
nomegestrol acetate
nomegestrol
chlormadinone
guidelines for drug use
pharmacovigilance note
meningioma
continuity of patient care
meningioma
risk
risk management
risk assessment
mass screening
meningioma

---
https://ansm.sante.fr/informations-de-securite/acetate-de-chlormadinone-et-acetate-de-nomegestrol-mesures-pour-reduire-le-risque-de-meningiome
https://ansm.sante.fr/actualites/acetate-de-nomegestrol-et-de-chlormadinone-et-meningiome-des-mesures-dans-lensemble-de-leurope-pour-limiter-le-risque
2022
false
false
false
France
French
drug information
meningioma
Drug-Related side effects and adverse reactions
risk management
chlormadinone acetate
nomegestrol acetate

---
https://ansm.sante.fr/actualites/medicaments-a-base-de-nomegestrol-et-de-chlormadinone-dont-lutenyl-luteran-et-generiques-lansm-a-exprime-sa-reserve-lors-du-vote-des-conclusions-du-prac-sur-la-reevaluation-de-leur-benefice-risque
2022
false
false
false
France
French
drug information
meningioma
chlormadinone acetate
nomegestrol acetate
drug evaluation
risk assessment
nomegestrol
chlormadinone
continuity of patient care
chlormadinone and ethinylestradiol
drug combinations
nomegestrol and estradiol

---
https://ansm.sante.fr/informations-de-securite/nouvelles-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-dacetate-de-nomegestrol-lutenyl-et-generiques-et-dacetate-de-chlomadinone-luteran-et-generiques-liees-au-risque-de-meningiome
2021
false
false
false
France
French
meningioma
guidelines for drug use
nomegestrol acetate
nomegestrol acetate
chlormadinone acetate
chlormadinone acetate
risk management
chlormadinone acetate
chlormadinone acetate
megestrol
norpregnadienes
megestrol
norpregnadienes

---
https://www.ansm.sante.fr/actualites/acetate-de-nomegestrol-lutenyl-et-generiques-acetate-de-chlormadinone-luteran-et-generiques-et-risque-de-meningiome-recommandations-dutilisation-et-de-suivi-des-patientes
2021
false
false
false
France
French
guidelines for drug use
continuity of patient care
drug monitoring
Drug-Related side effects and adverse reactions
nomegestrol acetate
nomegestrol
chlormadinone
chlormadinone acetate
risk
meningioma
risk assessment
meningioma
chlormadinone acetate
megestrol
norpregnadienes

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2021-acetate-nomegestrol-meningiome-intracranien
2021
France
technical report
acetate
meningioma, nos
intracranial meningioma
nomegestrol acetate
meningioma
risk
nomegestrol acetate
Meningioma
acetates
cranial cavity, nos
long

---
https://www.ansm.sante.fr/actualites/lutenyl-luteran-et-generiques-recommandations-preliminaires-suite-a-la-confirmation-du-sur-risque-de-meningiome
2020
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
meningioma
nomegestrol acetate
chlormadinone acetate
administration, oral
chlormadinone
nomegestrol
risk
patients guideline
chlormadinone acetate
megestrol
norpregnadienes

---
https://ansm.sante.fr/actualites/lutenyl-luteran-et-risque-de-meningiome-appel-a-participation-en-vue-dune-consultation-publique-1
2020
false
false
false
France
French
nomegestrol acetate
drug information
chlormadinone acetate
chlormadinone
nomegestrol
meningioma
chlormadinone acetate
megestrol
norpregnadienes

---
https://www.ansm.sante.fr/actualites/luteran-acetate-de-chlormadinone-et-lutenyl-acetate-de-nomegestrol-et-leurs-generiques-des-cas-de-meningiome-rapportes
2019
false
false
false
France
French
chlormadinone acetate
nomegestrol acetate
meningioma
pharmacovigilance
risk
administration, oral
nomegestrol
chlormadinone
pharmacovigilance note
megestrol
norpregnadienes

---
http://www.has-sante.fr/portail/jcms/c_2610185/fr/lutenyl
2016
true
France
French
hormone replacement therapy
treatment outcome
postmenopause
drug therapy, combination
menstruation disturbances
administration, oral
nomegestrol acetate
progesterone congeners
megestrol
norpregnadienes
nomegestrol
insurance, health, reimbursement
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1753533/fr/lutenyl
http://www.has-sante.fr/portail/jcms/c_748399/lutenyl
2014
false
France
French
hormone replacement therapy
treatment outcome
postmenopause
drug therapy, combination
administration, oral
nomegestrol acetate
progesterone congeners
megestrol
norpregnadienes
nomegestrol
insurance, health, reimbursement
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61335127
2012
France
summary of product characteristics
nomegestrol acetate
nomegestrol acetate
acetates
tablets
estradiol

---
https://www.ema.europa.eu/medicines/human/EPAR/Zoely
2012
United Kingdom
English
French
syndication feed
megestrol
megestrol
norpregnadienes
norpregnadienes
nomegestrol and estradiol
contraceptives, oral, combined
contraceptives, oral, combined
drug approval
treatment outcome
administration, oral
estradiol
nomegestrol acetate
nomegestrol acetate
estradiol
estrogens
estrogens
progestins
progestins
drug combinations
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation

---
https://www.ema.europa.eu/medicines/human/EPAR/Ioa
2012
United Kingdom
French
English
syndication feed
estradiol
nomegestrol acetate
drug combinations
contraceptives, oral, combined
contraceptives, oral, combined
drug approval
treatment outcome
nomegestrol and estradiol
nomegestrol acetate
progesterone congeners
progesterone congeners
estradiol
estrogens
estrogens
drug interactions
pregnancy
breast feeding
megestrol
megestrol
norpregnadienes
norpregnadienes
summary of product characteristics
package leaflet
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_399641
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct021197.pdf
2002
France
French
nomegestrol and estrogen
nomegestrol acetate
estradiol
estrogens
insurance, health, reimbursement
hormone replacement therapy
progesterone congeners
megestrol
norpregnadienes
drug combinations
administration, oral
megestrol
norpregnadienes
evaluation of the transparency committee

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.